Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China
· Delayed Price · Currency is CNY 4.470
+0.030 (0.68%)
Apr 29, 2026, 3:00 PM CST
SHA:600572 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 11,340 | 11,302 | 11,680 | 12,979 | 12,156 | 12,850 | Upgrade
|
| Market Cap Growth | -2.15% | -3.24% | -10.01% | 6.77% | -5.40% | 6.16% | Upgrade
|
| Enterprise Value | 10,658 | 10,968 | 11,398 | 12,136 | 11,898 | 13,766 | Upgrade
|
| Last Close Price | 4.47 | 4.46 | 4.50 | 4.69 | 4.30 | 4.39 | Upgrade
|
| PE Ratio | 23.13 | 23.83 | 18.77 | 21.94 | 33.95 | 6.37 | Upgrade
|
| Forward PE | - | 15.92 | 15.92 | 15.92 | 15.92 | 15.92 | Upgrade
|
| PS Ratio | 1.69 | 1.75 | 1.79 | 1.93 | 2.03 | 1.96 | Upgrade
|
| PB Ratio | 1.54 | 1.58 | 1.69 | 1.77 | 1.66 | 1.68 | Upgrade
|
| P/TBV Ratio | 1.69 | 1.74 | 1.86 | 2.00 | 1.92 | 1.93 | Upgrade
|
| P/FCF Ratio | 12.91 | 14.21 | 16.18 | 18.82 | 14.07 | 41.48 | Upgrade
|
| P/OCF Ratio | 11.20 | 11.99 | 11.54 | 14.44 | 10.52 | 14.42 | Upgrade
|
| PEG Ratio | - | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | Upgrade
|
| EV/Sales Ratio | 1.59 | 1.69 | 1.75 | 1.80 | 1.98 | 2.10 | Upgrade
|
| EV/EBITDA Ratio | 10.19 | 11.37 | 12.47 | 10.75 | 12.35 | 14.39 | Upgrade
|
| EV/EBIT Ratio | 15.41 | 17.57 | 19.65 | 15.09 | 17.23 | 20.42 | Upgrade
|
| EV/FCF Ratio | 12.13 | 13.79 | 15.79 | 17.60 | 13.78 | 44.43 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.04 | 0.06 | 0.17 | 0.16 | 0.20 | Upgrade
|
| Debt / EBITDA Ratio | 0.06 | 0.31 | 0.46 | 1.10 | 1.24 | 1.55 | Upgrade
|
| Debt / FCF Ratio | 0.07 | 0.38 | 0.59 | 1.80 | 1.39 | 4.82 | Upgrade
|
| Net Debt / Equity Ratio | -0.11 | -0.19 | -0.13 | -0.18 | -0.17 | -0.14 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.76 | -1.42 | -0.98 | -1.18 | -1.32 | -1.13 | Upgrade
|
| Net Debt / FCF Ratio | -0.90 | -1.72 | -1.24 | -1.93 | -1.47 | -3.49 | Upgrade
|
| Asset Turnover | 0.66 | 0.65 | 0.62 | 0.61 | 0.54 | 0.64 | Upgrade
|
| Inventory Turnover | 2.70 | 2.42 | 2.39 | 2.30 | 2.27 | 2.62 | Upgrade
|
| Quick Ratio | 1.15 | 1.34 | 1.22 | 1.38 | 1.49 | 1.37 | Upgrade
|
| Current Ratio | 1.98 | 1.87 | 1.76 | 1.82 | 1.93 | 1.73 | Upgrade
|
| Return on Equity (ROE) | 6.93% | 6.99% | 9.23% | 9.20% | 6.15% | 32.90% | Upgrade
|
| Return on Assets (ROA) | 4.32% | 3.92% | 3.43% | 4.54% | 3.89% | 4.10% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.47% | 8.06% | 8.14% | 11.71% | 8.54% | 9.06% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.00% | 8.30% | 7.90% | 10.00% | 8.50% | 8.30% | Upgrade
|
| Earnings Yield | 4.26% | 4.20% | 5.33% | 4.56% | 2.95% | 15.70% | Upgrade
|
| FCF Yield | 7.75% | 7.04% | 6.18% | 5.31% | 7.11% | 2.41% | Upgrade
|
| Dividend Yield | 3.38% | - | 3.33% | 4.26% | 3.49% | 3.65% | Upgrade
|
| Payout Ratio | 79.06% | 80.87% | 84.11% | 71.02% | 136.92% | 4.21% | Upgrade
|
| Buyback Yield / Dilution | 3.29% | 1.37% | 1.59% | -0.55% | 1.10% | -2.71% | Upgrade
|
| Total Shareholder Return | 6.68% | 1.37% | 4.92% | 3.71% | 4.59% | 0.94% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.